Prevalence of irritable bowel syndrome-like symptoms using Rome IV criteria in patients with inactive inflammatory bowel disease and relation with quality of life
被引:22
作者:
Ozer, Muhammet
论文数: 0引用数: 0
h-index: 0
机构:
Dokuz Eylul Univ, Dept Internal Med, TR-35035 Izmir, Turkey
Capital Hlth Reg Med Ctr, Dept Internal Med, Trenton, NJ USADokuz Eylul Univ, Dept Internal Med, TR-35035 Izmir, Turkey
Ozer, Muhammet
[1
,2
]
Bengi, Goksel
论文数: 0引用数: 0
h-index: 0
机构:
Dokuz Eylul Univ, Div Gastroenterol, Izmir, TurkeyDokuz Eylul Univ, Dept Internal Med, TR-35035 Izmir, Turkey
Irritable bowel syndrome (IBS)-like symptoms tend to be common in inflammatory bowel disease (IBD) patients even during the long-standing remission phase, and quality of life (QOL) seem to reduce in IBD patients with such symptoms. Thus, the aim of this study was to define the prevalence of IBS-like symptoms in inactive IBD patients using Rome IV criteria and evaluate the effect of IBS-like symptoms on QOL. Total 137 patients with IBD (56 with ulcerative colitis (UC) and 81 with Crohn disease (CD), who had been in long-standing remission according to the clinical scoring system and 123 control participants were included. These patients completed questionnaires to evaluate IBS-like symptoms according to Rome IV criteria, and the impact of these symptoms on the QOL of inactive IBD patients was compared with and without IBS-like symptoms according to disease-specific inflammatory bowel disease questionnaire (IBDQ). Depending on our research, IBS-like symptoms were found in 32% (18/56) of patients with inactive UC, 35% (29/81) of patients with inactive CD, and 13.8% (17/123) of control participants (P < .001). The QOL seemed to be significantly lower in both inactive UC and CD patients with IBS-like symptoms than in those without such symptoms (P < .001). In conclusion, we defined that the prevalence of IBS-like symptoms in IBD patients in remission is 2 to 3 times higher than that in healthy control participants, and significantly lower IBDQ scores showed QOL was reduced in inactive IBD patients with IBS-like symptoms as compared with patients without IBS-like symptoms.